Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

More articles from IMMUNOTHERAPY AND VACCINES

  • You have accessRestricted access
    Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1
    Gina M. Cusimano, Ebony N. Gary, Matthew R. Bell, Bryce M. Warner, Jennifer Connors, Nicholas J. Tursi, Ali R. Ali, Shiyu Zhang, Gabriela Canziani, Bhavani Taramangalam, Emma A. Gordon, Irwin M. Chaiken, Sarah K. Wootton, Trevor Smith, Stephanie Ramos, Darwyn Kobasa, David B. Weiner, Michele A. Kutzler and Elias K. Haddad
    J Immunol 209 (1) 118-127; July 1, 2022, doi: https://doi.org/10.4049/jimmunol.2200056
  • Open Access
    Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models
    Karine Lélu, Clarisse Dubois, Alexei Evlachev, Morgane Crausaz, Marie Baldazza, Nadine Kehrer, Renée Brandely, Yasmin Schlesinger, Nathalie Silvestre, Jean-Baptiste Marchand, Bérangère Bastien, Stéphane Leung-Theung-Long, Jacqueline Unsinger, Perrine Martin and Geneviève Inchauspé
    J Immunol 209 (1) 99-117; July 1, 2022, doi: https://doi.org/10.4049/jimmunol.2101145
  • You have accessRestricted access
    SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases
    Kin L. Wong, Zhengdong Li, Felix Ma, Dong Wang, Nan Song, Chi H. Chong, Ka K. Luk and Shui O. Leung
    J Immunol 208 (12) 2726-2737; June 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100820
  • You have accessRestricted access
    IL-10 Receptor Blockade Delivered Simultaneously with Bacillus Calmette–Guérin Vaccination Sustains Long-Term Protection against Mycobacterium tuberculosis Infection in Mice
    Varun Dwivedi, Shalini Gautam, Colwyn A. Headley, Tucker Piergallini, Jordi B. Torrelles and Joanne Turner
    J Immunol 208 (6) 1406-1416; March 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100900
  • You have accessRestricted access
    Development of a Nanoparticle Multiepitope DNA Vaccine against Virulent Infectious Bronchitis Virus Challenge
    Yifeng Qin, Qingyuan Teng, Delan Feng, Yu Pei, Ye Zhao and Guozhong Zhang
    J Immunol 208 (6) 1396-1405; March 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100909
  • Open Access
    Boosting of the SARS-CoV-2–Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine
    Alexey A. Komissarov, Inna V. Dolzhikova, Grigory A. Efimov, Denis Y. Logunov, Olga Mityaeva, Ivan A. Molodtsov, Nelli B. Naigovzina, Iuliia O. Peshkova, Dmitry V. Shcheblyakov, Pavel Volchkov, Alexander L. Gintsburg and Elena Vasilieva
    J Immunol 208 (5) 1139-1145; March 1, 2022, doi: https://doi.org/10.4049/jimmunol.2101052
  • Open Access
    Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity
    Matthew G. Booty, Kelan A. Hlavaty, Adam Stockmann, Emrah Ilker Ozay, Carolyne Smith, Lina Tian, Edylle How, Disha Subramanya, Anita Venkitaraman, Christian Yee, Olivia Pryor, Kelly Volk, Katarina Blagovic, Ildefonso Vicente-Suarez, Defne Yarar, Melissa Myint, Amy Merino, Jonathan Chow, Tarek Abdeljawad, Harry An, Sophia Liu, Shirley Mao, Megan Heimann, LeeAnn Talarico, Miye K. Jacques, Eritza Chong, Lucas Pomerance, John T. Gonzalez, Ulrich H. von Andrian, Klavs F. Jensen, Robert Langer, Hendrik Knoetgen, Christine Trumpfheller, Pablo Umaña, Howard Bernstein, Armon Sharei and Scott M. Loughhead
    J Immunol 208 (4) 929-940; February 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100656
  • Open Access
    Mucosal Vaccination with Cyclic Dinucleotide Adjuvants Induces Effective T Cell Homing and IL-17–Dependent Protection against Mycobacterium tuberculosis Infection
    Robyn M. Jong, Erik Van Dis, Samuel B. Berry, Xammy Nguyenla, Alexander Baltodano, Gabrielle Pastenkos, Chenling Xu, Douglas Fox, Nir Yosef, Sarah M. McWhirter and Sarah A. Stanley
    J Immunol 208 (2) 407-419; January 15, 2022, doi: https://doi.org/10.4049/jimmunol.2100029
  • Open Access
    Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy
    Chris Y. Chiu, Judy J. Chang, Ashanti I. Dantanarayana, Ajantha Solomon, Vanessa A. Evans, Rachel Pascoe, Céline Gubser, Lydie Trautman, Rémi Fromentin, Nicolas Chomont, James H. McMahon, Paul U. Cameron, Thomas A. Rasmussen and Sharon R. Lewin
    J Immunol 208 (1) 54-62; January 1, 2022, doi: https://doi.org/10.4049/jimmunol.2100367
  • You have accessRestricted access
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses
    Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta and Kalipada Pahan
    J Immunol 207 (10) 2521-2533; November 15, 2021, doi: https://doi.org/10.4049/jimmunol.2100144

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 40

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606